Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Monitoring During Systemic Therapy of Metastatic Malignant Melanoma

NCT04158544 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT04158544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Monitoring During Systemic Therapy of Metastatic Malignant Melanoma
Lead sponsor
University of Regensburg
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2016
Completion date
July 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma